Small Interference RNAs (siRNAs)
Studies from University of Tel Aviv Have Provided New Information about Small Interference RNAs (siRNAs)
Published in Gene Therapy Weekly, December 8th, 2011
"Nevertheless, in vivo delivery of siRNA remains a crucial challenge for its therapeutic success. siRNAs on their own are not taken-up by most mammalian cells in a way that preserves their activity," wrote W. Fischer and colleagues, University of Tel Aviv.
The researchers concluded: "Moreover, when applied in vivo, siRNA-based approaches are all limited by poor penetration into the target...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-12-08)
More Articles from Gene Therapy Weekly
- Leukemia
Findings in Leukemia Reported from National Sun Yat Sen University - Gene Therapy
Food and Drug Administration Reports Research in Gene Therapy - Small Interference RNAs (siRNAs)
Investigators from Shanghai Jiao Tong University Publish New Data on Small Interference RNAs (siRNAs) - Aromatic Amino Acids
New Aromatic Amino Acids Study Results Reported from Jiangsu University - Edema
New Edema Study Findings Recently Were Published by Researchers at Oslo University Hospital - Gene Therapy
New Gene Therapy Data Have Been Reported by Investigators at Oregon Health and Science University - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
